SmartDTI: Deep Feature-based Prediction of Drug-Target Interactions
Keywords:
Branch chain mining (BCM), Computational drug discovery, Deep learning in drug discovery, Drug-target interaction (DTI), Feature fusion (Structural, Chemical, Sequence), Personalized medicineAbstract
Drug-target interaction (DTI) is critical in understanding how drugs interact with biological molecules, such as proteins and nucleic acids, to produce therapeutic effects. Accurate prediction of DTIs is a cornerstone in drug discovery and development, influencing both the effectiveness and safety of therapeutic agents. Branch Chain Mining-Drug Target Interaction (BCM-DTI) represents an innovative approach that leverages deep learning techniques to predict DTIs with enhanced accuracy and computational efficiency. By integrating structural, chemical, and sequence-based features through a branch chain mining architecture, BCM-DTI captures complex, non-linear relationships between drugs and targets that traditional methods may overlook. Notably, BCM-DTI exhibits superior performance compared to existing state-of-the-art methods on publicly available benchmark datasets, achieving these results with significantly reduced training time. This improvement in efficiency not only lowers computational resource demands but also holds the promise of expediting the drug discovery pipeline. Faster and more accurate DTI prediction could lead to earlier identification of viable therapeutic candidates, accelerating the development of novel treatments and potentially offering life-saving interventions to patients more quickly. The robust generalization ability of BCM-DTI also suggests its potential adaptability across diverse biomedical applications, including drug repurposing and personalized medicine.
References
P. Bongini, F. Scarselli, M. Bianchini, G. M. Dimitri, N. Pancino, and P. Liò, “Modular multi–source prediction of drug side–effects with DruGNN,” IEEE/ACM Transactions on Computational Biology and Bioinformatics, vol. 20, no. 2, pp. 857–868, 2023.
Y. Berker, D. ElHarouni, H. Peterziel, P. Fiesel, O. Witt, I. Oehme, M. Schlesner, and S. Oppermann, “Patient-by-patient deep transfer learning for drug-response profiling using confocal fluorescence microscopy of pediatric patient-derived tumor-cell spheroids,” IEEE Transactions on Medical Imaging, vol. 41, no. 12, pp. 3403–3414, 2022.
X. Wang, X. Wang, and S. Zhang, “Adverse drug reaction detection from social media based on quantum Bi-LSTM with attention,” IEEE Access, vol. 11, pp. 22090–22100, 2023.
B. Fan, W. Fan, C. Smith, and H. S. Garner, “Adverse-drug event detection and extraction from open data: A deep learning approach,” Information Processing & Management, vol. 57, no. 1, Art. no. 102131, Jan. 2020.
J. Y. Ryu, H. U. Kim, and S. Y. Lee, “Deep learning improves prediction of drug–drug and drug–food interactions,” Proceedings of the National Academy of Sciences of the United States of America, vol. 115, no. 18, pp. E4304–E4311, Apr. 2018.
M. Abdel-Basset, M. Elhoseny, R. K. Chakrabortty, and M. Ryan, “DeepHDT: Deep learning for predicting drug–target interactions—A case study of COVID-19 drug repurposing,” IEEE Access, vol. 8, pp. 174175–174190, 2020.
B. Zhao, “DrunaliaCap: Image captioning for drug-related paraphernalia with deep learning,” IEEE Access, vol. 8, pp. 160915–160926, 2020.
Aliper, S. Plis, A. Artemov, A. Ulloa, P. Mamoshina, and A. Zhavoronkov, “Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data,” Molecular Pharmaceutics, vol. 13, no. 7, pp. 2524–2530, Jul. 2016.
Aliper, S. Plis, A. Artemov, A. Ulloa, P. Mamoshina, and A. Zhavoronkov, “Efficient prediction of drug–drug interaction using deep learning models,” IET Systems Biology, vol. 14, no. 4, pp. 211–216, Aug. 2020.
J. Liu, Z. Huang, F. Ren, and L. Hua, “Drug-drug interaction extraction based on transfer weight matrix and memory network,” IEEE Access, vol. 7, pp. 136059–136068, 2019.
J. Zhu, Y. Liu, Y. Zhang, Z. Chen, K. She, and R. Tong, “DAEM: Deep attributed embedding based multi-task learning for predicting adverse drug–drug interaction,” Expert Systems with Applications, vol. 215, p. 119312, 2023.
D. Krentzel, S. L. Shorte, and C. Zimmer, “Deep learning in image-based phenotypic drug discovery,” Trends in Cell Biology, vol. 33, no. 7, pp. 544–556, 2023.
R. Duwairi and A. Melhem, “A deep-learning based framework for automatic detection of drug resistance in tuberculosis patient,” Egyptian Informatics Journal, vol. 24, no. 1, pp. 1–10, 2023.
S. Yang and S. Kar, “Application of artificial intelligence and machine learning in early detection of adverse drug reactions (ADRs) and drug-induced toxicity,” Artificial Intelligence Chemistry, vol. 1, no. 2, p. 100011, 2023.
Z. Cheng, C. Yan, F.-X. Wu, and J. Wang, “Drug-target interaction prediction using multi-head self-attention and graph attention network,” IEEE/ACM Transactions on Computational Biology and Bioinformatics, vol. 19, no. 4, pp. 2208–2218, 2022.
S. Budennyy, A. Kazakov, E. Kovtun, and L. Zhukov, “New drugs and stock market: a machine learning framework for predicting pharma market reaction to clinical trial announcements,” Scientific Reports, vol. 13, no. 1, p. 7897, 2023.
W.-L. Yang, Q. Li, J. Sun, S. H. Tan, Y.-H. Tang, M.-M. Zhao, Y.-Y. Li, X. Cao, J.-C. Zhao, and J.-K. Yang, “Potential drug discovery for COVID-19 treatment targeting Cathepsin L using a deep learning-based strategy,” Computational and Structural Biotechnology Journal, vol. 20, pp. 1536–1547, 2022.
J. Kim, S. Park, D. Min, and W. Kim, “Comprehensive survey of recent drug discovery using deep learning,” International Journal of Molecular Sciences, vol. 22, no. 18, p. 9983, 2021.
I. Saad, Y. M. K. Omar, and F. A. Maghrab, “Predicting drug interaction with adenosine receptors using machine learning and SMOTE techniques,” IEEE Access, vol. 7, pp. 141898–141906, 2019.
W. Ma, S. Zhang, Z. Li, M. Jiang, S. Wang, N. Guo, Y. Li, X. Bi, H. Jiang, and Z. Wei, “Predicting drug-target affinity by learning protein knowledge from biological networks,” IEEE Journal of Biomedical and Health Informatics, vol. 27, no. 4, pp. 1612–1623, Apr. 2023.
